TOKYO -- Around 25 Japanese companies including Eisai and Takeda Pharmaceutical plan to jointly develop and distribute medicines in emerging economies, leveraging a government partnership to take on Western giants.
The group will aim to develop markets for medicines in such regions as Asia and Africa. Members will form a corporation within the year under government leadership and kick off operations in Vietnam and Thailand in fiscal 2019.
